At this rate we have to hope some type of federal involvement happens soon, like mgmt...and the X-echo-chamber...is anticipating it will. The company might be proving ability in highly competitive markets, compared to others...or the average...in those markets, but an MSO in established/competitive markets isn't the shiny object to an investor. Until national normalization, investors will seek operators in medical flipping to adult use states where the average flower price is 3x-5x that of CO & NM...and operator inefficiency/inability is easily masked by profit margin.
News 
Market Data 
Discover 
